Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

February 11, 2020

Amgen Inc. et al v. Hospira, Inc. et al

Track this case

Case Number:

1:20-cv-00201

Court:

Delaware

Nature of Suit:

Patent

Judge:

Colm F. Connolly

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 21, 2022

    Amgen Agrees To End Neulasta IP Suit Against Pfizer, Hospira

    Biopharmaceutical company Amgen has agreed to drop its patent infringement suit against its rivals, Pfizer and Hospira, asking a Delaware federal judge Monday to end the two-year feud over claims of their post-chemotherapy treatment being nearly identical to Amgen's Neulasta.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login